FRIEDBERG ALBERT 4

4 · VACCINEX, INC. · Filed May 31, 2024

Form 4

Period: 2024-05-29

Director10% Owner

Transactions

Purchase
Common Stock
2024-05-29$4.95/sh+957$4,737→ 561,554 total(indirect: By FCMI Parent Co.)
Purchase
Common Stock
2024-05-30$5.20/sh+861$4,473→ 562,415 total(indirect: By FCMI Parent Co.)

Holdings

Common Stock
(indirect: By Pan Atlantic Holdings Ltd.)
180
Warrant (Right to Buy)
(indirect: By FCMI Parent Co.)
Exercise: $7.64From: 2024-03-28Exp: 2029-03-28→ Common Stock (102,960 underlying)
102,960
Warrant (Right to Buy)
(indirect: By FCMI Parent Co.)
Exercise: $14.00From: 2023-10-03Exp: 2028-10-03→ Common Stock (214,285 underlying)
214,285
Common Stock
2,094
Warrant (Right to Buy)
(indirect: By FCMI Parent Co.)
Exercise: $14.00From: 2024-02-08Exp: 2029-02-08→ Common Stock (118,226 underlying)
118,226
Common Stock
(indirect: By Friedberg Global-Macro Hedge Fund Ltd.)
16,724

Footnotes (4)

[F1]Mr. Friedberg is the majority owner of Pan Atlantic Holdings Ltd. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F2]Mr. Friedberg possesses voting and dispositive power over the reported securities and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F3]Mr. Friedberg is the majority owner, a director and the president of FCMI Parent Co. and disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
[F4]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.17 to $5.20. The reporting persons undertake to provide Vaccinex, Inc., any security holder of Vaccinex, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

2 files